A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This study is a multicenter, randomized, double-blinded, parallel-group Phase III clinical study to compare the clinical efficacy, safety, and immunogenicity of 9MW0311 and Prolia® in Chinese postmenopausal women with osteoporosis at high risk for fracture.
Epistemonikos ID: 95adf8ca19c7248bd86155cce1680f9caae3fbcd
First added on: Mar 27, 2025